speb/financial-data huggingface dataset:
Financial ratios for 6757.T — quarterly report dated 2025-07-31
Capital expenditures: 0
Net tangible assets: 14802017.020706294
Buffett classification: The Gruesome
Stock price: 5.228975407089728
Shares outstanding: 5220313
Book value: 19315573.27615091
P/B ratio: 1.4132062198751556
Market cap (USD): 27296888.2943108
Debt to equity: 0.6793179999188195
Current ratio: 1.4196931344813375
Quick ratio: 1.1724233095906729
Buyback yield (%): 0
Retained earnings: 9813998.525765598
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6757.T — quarterly report dated 2026-01-31
Capital expenditures: 0
Net tangible assets: 14463149.647427527
Buffett classification: The Gruesome
Stock price: 5.360407417080178
Shares outstanding: 5220313
Book value: 18371924.784539048
P/B ratio: 1.5231395105769898
Market cap (USD): 27983004.524680074
Debt to equity: 0.7162113464712329
Current ratio: 1.5233699702300827
Quick ratio: 1.2400969180527428
Buyback yield (%): 0
Retained earnings: 9452866.283624968
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6757.T — annual report dated 2026-01-31
Total revenue: 53442217.28910943
Gross profit: 31434878.558370333
Operating income: 1356542.1781143902
Net income: 696585.2703055629
Capital expenditures: 1969241.3162705668
Operating cash flow: 618111.7785322538
Depreciation & amortization: 1167054.061112562
Net tangible assets: 14463149.647427527
Owner earnings: -105601.98485244182
Return on net tangible assets (%): -0.7301451442233028
Capex to operating income (%): 145.16624311732315
Buffett classification: The Gruesome
Stock price: 5.360407417080178
P/E ratio: 40.17168567518675
Shares outstanding: 5220313
Book value: 18371924.784539048
P/B ratio: 1.5231395105769898
Market cap (USD): 27983004.524680074
Debt to equity: 0.7162113464712329
Current ratio: 1.5233699702300827
Quick ratio: 1.2400969180527428
Effective tax rate (%): 73.21296856206848
Interest coverage ratio: 10.437980406932931
COGS to revenue (%): 41.17967651410287
Free cash flow (dilution-adjusted): -2321937.8427787935
Buyback yield (%): 0.0028232261626330167
Retained earnings: 9452866.283624968
Inventory turnover: 4.642592689518006
Receivables turnover: 10.400335953362964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.324259684508246
FCF margin (%): -4.344763298681402
Revenue growth (%): 3.85261223106672
Rule of 40 score: -0.49215106761468164
Financial ratios for 6993.HK — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7948717948717949
Shares outstanding: 5798933256
Market cap (USD): 4609408485.538462
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6993.HK — annual report dated 2022-12-31
Total revenue: 1141771982.7586207
Gross profit: 660264511.4942529
Operating income: 127966379.31034483
Net income: 87839942.52873564
Capital expenditures: 37237212.64367816
Operating cash flow: 80556465.51724137
Depreciation & amortization: 36282183.90804598
Net tangible assets: 1523952155.1724138
Owner earnings: 86884913.79310346
Return on net tangible assets (%): 5.70128881659501
Capex to operating income (%): 29.099215625512265
Buffett classification: The Good
Stock price: 0.5738125802310654
P/E ratio: 37.88140973708569
Shares outstanding: 5798933256
Book value: 1590916666.6666665
P/B ratio: 2.0915620056862982
Market cap (USD): 3327500854.2130933
Debt to equity: 0.018022574276739898
Current ratio: 7.273708483074934
Quick ratio: 7.082380432237339
Effective tax rate (%): 27.04959209218466
Interest coverage ratio: 92.93050918196995
COGS to revenue (%): 42.171946635176994
SG&A to revenue (%): 47.30971834589132
Free cash flow (dilution-adjusted): 34350431.03448276
Buyback yield (%): 0
Retained earnings: 279917672.4137931
Inventory turnover: 12.28029314767314
Receivables turnover: 3.921713610042135
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.87946683907529
FCF margin (%): 3.008519350027238
Rule of 40 score: 3.008519350027238
Financial ratios for 6993.HK — annual report dated 2023-12-31
Total revenue: 1030032630.0984528
Gross profit: 638596343.1786216
Operating income: 31038959.212376934
Net income: 45753727.144866385
Capital expenditures: 11556680.731364274
Operating cash flow: 105389029.53586498
Depreciation & amortization: 35689451.476793244
Net tangible assets: 1399860900.140647
Owner earnings: 69886497.89029536
Return on net tangible assets (%): 4.992388735428907
Capex to operating income (%): 37.232822957401204
Buffett classification: The Good
Stock price: 0.24583866837387963
P/E ratio: 31.15816171937809
Shares outstanding: 5798933256
Book value: 1459781012.658228
P/B ratio: 0.9765862257983868
Market cap (USD): 1425602029.644046
Debt to equity: 0.015309311272725239
Current ratio: 6.695911267290138
Quick ratio: 6.515197821582572
Effective tax rate (%): 17.83238067333655
Interest coverage ratio: 32.869675305332144
COGS to revenue (%): 38.002319099582
SG&A to revenue (%): 59.512076959587255
Free cash flow (dilution-adjusted): 89253305.20393811
Buyback yield (%): 0
Retained earnings: 175346554.1490858
Inventory turnover: 10.78057018903006
Receivables turnover: 4.996961647710796
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.0772337861505386
FCF margin (%): 8.665094929605004
Revenue growth (%): -9.78648577364772
Rule of 40 score: -1.1213908440427165
Financial ratios for 6993.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1131232328.7671232
Buffett classification: The Gruesome
Stock price: 0.3711340206185567
Shares outstanding: 5798933256
Book value: 1186931369.8630137
P/B ratio: 1.8132315559629417
Market cap (USD): 2152181414.597938
Debt to equity: 0.011502436523605997
Current ratio: 5.457991132974497
Quick ratio: 5.115735320131068
Buyback yield (%): 0
Retained earnings: -14413561.643835617
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 6993.HK — annual report dated 2024-12-31
Total revenue: 1172000136.9863014
Gross profit: 710059726.0273973
Operating income: -128849726.02739726
Net income: -102645479.4520548
Capital expenditures: 17315205.479452055
Operating cash flow: -122576438.35616438
Depreciation & amortization: 32158356.164383564
Net tangible assets: 1131232328.7671232
Owner earnings: -87802328.7671233
Return on net tangible assets (%): -7.761653069340311
Buffett classification: The Gruesome
Stock price: 0.3711340206185567
Shares outstanding: 5798933256
Book value: 1186931369.8630137
P/B ratio: 1.8132315559629417
Market cap (USD): 2152181414.597938
Debt to equity: 0.011502436523605997
Current ratio: 5.457991132974497
Quick ratio: 5.115735320131068
Interest coverage ratio: -202.1932502149613
COGS to revenue (%): 39.41470622578122
SG&A to revenue (%): 71.90336482498424
Free cash flow (dilution-adjusted): -151707260.2739726
Buyback yield (%): 0
Retained earnings: -14413561.643835617
Inventory turnover: 6.916140768983078
Receivables turnover: 9.05412089656486
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.591190580694008
FCF margin (%): -12.94430397116462
Revenue growth (%): 13.782816460317285
Rule of 40 score: 0.8385124891526647
Financial ratios for 6993.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1070532635.9832636
Buffett classification: The Gruesome
Stock price: 0.4955414012738854
Shares outstanding: 5798933256
Book value: 1084637656.9037657
P/B ratio: 2.649374649018788
Market cap (USD): 2873611511.5719748
Debt to equity: 0.010957004196556654
Current ratio: 5.915150987968575
Quick ratio: 5.550042119142234
Buyback yield (%): 0
Retained earnings: -75390237.09902371
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7747.T — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 23.011308123756105
Shares outstanding: 265324323
Market cap (USD): 6105459749.279989
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7747.T — annual report dated 2022-06-30
Total revenue: 569207116.1871294
Gross profit: 373980525.6607365
Operating income: 111596749.39600264
Net income: 80481733.65546526
Capital expenditures: 58430338.97064207
Operating cash flow: 126671059.37477121
Depreciation & amortization: 54711179.44212607
Net tangible assets: 732842814.2616589
Owner earnings: 76762574.12694928
Return on net tangible assets (%): 10.47463011618498
Capex to operating income (%): 52.35845962080955
Buffett classification: The Good
Stock price: 14.443663518559191
P/E ratio: 47.6164599175639
Shares outstanding: 265324323
Book value: 886792590.9656637
P/B ratio: 4.321478645337373
Market cap (USD): 3832255244.701515
Debt to equity: 0.10054735938312678
Current ratio: 3.8345455421222483
Quick ratio: 2.5361976783391933
Effective tax rate (%): 30.114431023521938
Interest coverage ratio: 108.1063829787234
COGS to revenue (%): 34.29798837269126
R&D to revenue (%): 11.407367392087256
SG&A to revenue (%): 3.720996038483305
Free cash flow (dilution-adjusted): 64001757.08324182
Buyback yield (%): 0
Retained earnings: 505293213.26597846
Inventory turnover: 0.9892784270079762
Receivables turnover: 5.558590119396583
Capitalized R&D asset: 64931546.96537082
ROCI (R&D-adjusted, %): 14.769900280424944
FCF margin (%): 11.24401913875598
Rule of 40 score: 11.24401913875598
Financial ratios for 7747.T — annual report dated 2023-06-30
Total revenue: 622330432.380163
Gross profit: 406354468.8492886
Operating income: 124568310.54012986
Net income: 91697748.30777732
Capital expenditures: 84894322.42022379
Operating cash flow: 132186766.12791821
Depreciation & amortization: 60167150.15886172
Net tangible assets: 787000966.9843901
Owner earnings: 66970576.046415254
Return on net tangible assets (%): 8.509592599743728
Capex to operating income (%): 68.15081785417244
Buffett classification: The Good
Stock price: 18.80135377814615
P/E ratio: 54.40107914020638
Shares outstanding: 265324323
Book value: 927600497.3062577
P/B ratio: 5.3778070162279406
Market cap (USD): 4988456462.670119
Debt to equity: 0.10612965196801144
Current ratio: 3.429890560875513
Quick ratio: 2.2383340933272535
Effective tax rate (%): 25.1761257960886
Interest coverage ratio: 58.55519480519481
COGS to revenue (%): 34.703277433102855
R&D to revenue (%): 10.791223182872555
SG&A to revenue (%): 3.3595631569016993
Free cash flow (dilution-adjusted): 44377676.474651195
Buyback yield (%): 0
Retained earnings: 544736842.1052631
Inventory turnover: 0.9971617182766209
Receivables turnover: 6.138506608529772
Capitalized R&D asset: 110661202.3598776
ROCI (R&D-adjusted, %): 13.171213794876152
Rosenberg metric: 0.4985857368501893
FCF margin (%): 7.130886449650947
Revenue growth (%): 9.33286227144937
Rule of 40 score: 16.463748721100316
Financial ratios for 7747.T — annual report dated 2024-06-30
Total revenue: 669282469.3509241
Gross profit: 429728047.79388887
Operating income: 137774597.05022094
Net income: 98923392.86825565
Capital expenditures: 61466177.11120792
Operating cash flow: 215993527.91088432
Depreciation & amortization: 60482917.41863215
Net tangible assets: 835490696.3718963
Owner earnings: 97940133.17567988
Return on net tangible assets (%): 11.722468436929722
Capex to operating income (%): 44.61357784904467
Buffett classification: The Good
Stock price: 13.715228078909703
P/E ratio: 36.785875406372675
Shares outstanding: 265324323
Book value: 945659344.0786607
P/B ratio: 3.848091416442044
Market cap (USD): 3638983604.8273077
Debt to equity: 0.05398860211374196
Current ratio: 3.210686919373432
Quick ratio: 2.215806604733166
Effective tax rate (%): 27.045757033365458
Interest coverage ratio: 97.96017699115046
COGS to revenue (%): 35.79272318149275
R&D to revenue (%): 10.843631156610597
SG&A to revenue (%): 2.555161929203046
Free cash flow (dilution-adjusted): 150376501.33797997
Buyback yield (%): 0
Retained earnings: 564702221.6690522
Inventory turnover: 1.3118631360119961
Receivables turnover: 6.084351663272233
Capitalized R&D asset: 138997167.019205
ROCI (R&D-adjusted, %): 12.381612837244694
Rosenberg metric: 0.3480434803660629
FCF margin (%): 22.46831617804309
Revenue growth (%): 7.544551017887486
Rule of 40 score: 30.012867195930575
Financial ratios for 7747.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 17.25255638044544
Shares outstanding: 265324323
Market cap (USD): 4577522841.661017
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7747.T — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 909312695.0761194
Buffett classification: The Gruesome
Stock price: 15.943941217457402
Shares outstanding: 265324323
Book value: 1012287406.8412
P/B ratio: 4.17896674490321
Market cap (USD): 4230315409.473681
Debt to equity: 0.02247685928051397
Current ratio: 4.6964294732589265
Quick ratio: 3.332205444169486
Buyback yield (%): 0
Retained earnings: 620873941.0153513
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7747.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1003044561.3063935
Buffett classification: The Gruesome
Stock price: 15.605037365070576
Shares outstanding: 265324323
Book value: 1047259894.8242457
P/B ratio: 3.953551544119722
Market cap (USD): 4140395974.2770543
Debt to equity: 0.07332672613148332
Current ratio: 3.710475301550833
Quick ratio: 2.825531303848363
Buyback yield (%): 0
Retained earnings: 677740105.1757542
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 7747.T — annual report dated 2025-06-30
Total revenue: 830507888.1815665
Gross profit: 562102131.1929145
Operating income: 208158040.40963188
Net income: 88513700.52587877
Capital expenditures: 56019928.037641846
Operating cash flow: 280535566.0116247
Depreciation & amortization: 70197896.48491558
Net tangible assets: 1003044561.3063935
Owner earnings: 102691668.97315249
Return on net tangible assets (%): 10.23799668874172
Capex to operating income (%): 26.912209553568463
Buffett classification: The Good
Stock price: 15.605037365070576
P/E ratio: 46.7768938557317
Shares outstanding: 265324323
Book value: 1047259894.8242457
P/B ratio: 3.953551544119722
Market cap (USD): 4140395974.2770543
Debt to equity: 0.07332672613148332
Current ratio: 3.710475301550833
Quick ratio: 2.825531303848363
Effective tax rate (%): 31.428571428571427
Interest coverage ratio: 140.57476635514018
COGS to revenue (%): 32.31743386794418
R&D to revenue (%): 10.204540720683191
SG&A to revenue (%): 2.4569881274734433
Free cash flow (dilution-adjusted): 221180459.45197895
Buyback yield (%): 0.7430185011465196
Retained earnings: 677740105.1757542
Inventory turnover: 1.5735264289481157
Receivables turnover: 7.612418342106932
Capitalized R&D asset: 155536277.37211072
ROCI (R&D-adjusted, %): 16.781400093911934
Rosenberg metric: 1.8239745722337015
FCF margin (%): 26.631951676734015
Revenue growth (%): 24.089293566436922
Rule of 40 score: 50.72124524317094
Financial ratios for 7747.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 15.960834454912519
Shares outstanding: 265324323
Market cap (USD): 4234797596.264738
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9271.T — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.413658112222705
Shares outstanding: 7533724
Market cap (USD): 25717558.047846887
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9271.T — annual report dated 2022-12-31
Total revenue: 7499571.17062895
Gross profit: 5641701.775504063
Operating income: -1529468.8534456817
Net income: -614098.7059885646
Capital expenditures: 353708.9978934698
Operating cash flow: -948916.6415889257
Depreciation & amortization: 161412.8799277761
Net tangible assets: -3575022.569966898
Owner earnings: -806394.8239542583
Buffett classification: The Gruesome
Stock price: 3.1987661751429433
Shares outstanding: 7533724
Book value: -3323961.781522721
Market cap (USD): 24098621.504062597
Debt to equity: -1.3347984817380794
Current ratio: 0.3430246103805927
Quick ratio: 0.2773559937518579
Interest coverage ratio: -43.40243381725021
COGS to revenue (%): 24.773008387479273
Free cash flow (dilution-adjusted): -1421892.8678904606
Buyback yield (%): 0
Retained earnings: -13305048.149262715
Inventory turnover: 4.315990002971144
Receivables turnover: 18.999066097430813
Capitalized R&D asset: 0
FCF margin (%): -18.959655632832856
Rule of 40 score: -18.959655632832856
Financial ratios for 9271.T — annual report dated 2023-12-31
Total revenue: 9410506.964576116
Gross profit: 6428629.003747436
Operating income: 343958.14183695114
Net income: -73110.37262249876
Capital expenditures: 93183.90723326027
Operating cash flow: -2441766.244785406
Depreciation & amortization: 132701.68988192038
Net tangible assets: 865714.4877324471
Owner earnings: -33592.58997383865
Return on net tangible assets (%): -3.8803312697038503
Capex to operating income (%): 27.091641656045717
Buffett classification: The Good
Stock price: 2.6410238280421408
Shares outstanding: 7533724
Book value: 1010909.990808174
P/B ratio: 19.682014006001125
Market cap (USD): 19896744.597892947
Debt to equity: 3.6921446706720835
Current ratio: 0.832483422385436
Quick ratio: 0.6307226024927959
Effective tax rate (%): 196.07879576286936
Interest coverage ratio: 8.6404973357016
COGS to revenue (%): 31.686612649219192
Free cash flow (dilution-adjusted): -2914310.9665558934
Buyback yield (%): 0
Retained earnings: -12599681.821395744
Inventory turnover: 2.598499038793316
Receivables turnover: 13.105489636157747
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 22.08110537161948
FCF margin (%): -30.968692521308437
Revenue growth (%): 25.480600829965933
Rule of 40 score: -5.488091691342504
Financial ratios for 9271.T — annual report dated 2024-12-31
Total revenue: 13344455.060831899
Gross profit: 9058653.417415122
Operating income: 2653589.400598764
Net income: 2550060.5134084974
Capital expenditures: 241658.7043760749
Operating cash flow: 1260284.0945283137
Depreciation & amortization: 107510.0324861456
Net tangible assets: 3343365.8194789477
Owner earnings: 2415911.841518568
Return on net tangible assets (%): 72.2598713979519
Capex to operating income (%): 9.106861231867533
Buffett classification: The Great
Stock price: 3.184012161905365
P/E ratio: 9.406627299356073
Shares outstanding: 7533724
Book value: 3620313.395757691
P/B ratio: 6.625798989818678
Market cap (USD): 23987468.840438336
Debt to equity: 0.7625665739426026
Current ratio: 1.3751635055591889
Quick ratio: 1.0341137998691956
Effective tax rate (%): 4.927294618875614
Interest coverage ratio: 68.2817570890018
COGS to revenue (%): 32.116722817676454
Free cash flow (dilution-adjusted): 903770.9408242563
Buyback yield (%): 0
Retained earnings: -3086782.5976176825
Inventory turnover: 3.2256623167422553
Receivables turnover: 22.028179973292115
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 62.751764289426305
FCF margin (%): 6.772632802945757
Revenue growth (%): 41.80378497209882
Rule of 40 score: 48.576417775044575
Financial ratios for 9271.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.954618366528539
Shares outstanding: 7533724
Market cap (USD): 22259279.298756853
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9271.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 5612551.895931358
Buffett classification: The Gruesome
Stock price: 3.0725851093274286
Shares outstanding: 7533724
Book value: 5790464.987544976
P/B ratio: 3.997607831145335
Market cap (USD): 23148008.180182673
Debt to equity: 0.5146503863352285
Current ratio: 1.831466439323971
Quick ratio: 1.4640770912765133
Buyback yield (%): 0
Retained earnings: -1503951.010240797
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9271.T — annual report dated 2025-12-31
Total revenue: 17798350.489099164
Gross profit: 12513240.841378428
Operating income: 3629640.048590244
Net income: 4519237.900390001
Capital expenditures: 1278530.7844766958
Operating cash flow: 3900990.9852311234
Depreciation & amortization: 165628.79611278052
Net tangible assets: 8082533.086119814
Owner earnings: 3406335.912026086
Return on net tangible assets (%): 42.14441036901919
Capex to operating income (%): 35.22472662194915
Buffett classification: The Good
Stock price: 5.482469072495354
P/E ratio: 9.139463277016592
Shares outstanding: 7533724
Book value: 8103842.465315517
P/B ratio: 5.096768478347743
Market cap (USD): 41303408.830715984
Debt to equity: 0.2788898338648166
Current ratio: 2.452266644688192
Quick ratio: 1.8749264522391718
Effective tax rate (%): -27.103896080543333
Interest coverage ratio: 69.33463605276013
COGS to revenue (%): 29.69434306569343
Free cash flow (dilution-adjusted): 2599731.474969631
Buyback yield (%): 0
Retained earnings: 1421002.4934467105
Inventory turnover: 3.278026941394338
Receivables turnover: 23.537409214275446
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.72594783604173
FCF margin (%): 14.606586585435943
Revenue growth (%): 33.37637549052233
Rule of 40 score: 47.98296207595827
Financial ratios for 9271.T — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 8082533.086119814
Buffett classification: The Gruesome
Stock price: 5.482469072495354
Shares outstanding: 7533724
Book value: 8103842.465315517
P/B ratio: 5.096768478347743
Market cap (USD): 41303408.830715984
Debt to equity: 0.2788898338648166
Current ratio: 2.452266644688192
Quick ratio: 1.8749264522391718
Buyback yield (%): 0
Retained earnings: 1421002.4934467105
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACLN.SW — annual report dated 2022-12-31
Total revenue: 848410869.5652174
Gross profit: 383504347.82608694
Operating income: 170693478.26086956
Net income: 141078260.86956522
Capital expenditures: 37051086.956521735
Operating cash flow: 144986956.52173913
Depreciation & amortization: 24722826.08695652
Net tangible assets: 297005434.7826087
Owner earnings: 128750000.00000001
Return on net tangible assets (%): 43.34937510292961
Capex to operating income (%): 21.70621123549714
Buffett classification: The Great
Stock price: 18.858695652173914
P/E ratio: 12.570961669055105
Shares outstanding: 94040937
Book value: 322289130.4347825
P/B ratio: 5.502790017571316
Market cap (USD): 1773489409.728261
Debt to equity: 1.183439795484746
Current ratio: 2.1470411597927344
Quick ratio: 1.502884118493275
Effective tax rate (%): 17.05680489254424
Interest coverage ratio: 282.9513513513513
COGS to revenue (%): 54.797332096579545
R&D to revenue (%): 6.545100943195591
SG&A to revenue (%): 19.166523602950782
Free cash flow (dilution-adjusted): 107568478.26086956
Buyback yield (%): 0
Retained earnings: 133479347.82608695
Inventory turnover: 2.3184341189479847
Receivables turnover: 4.205530232006811
Capitalized R&D asset: 55529347.82608695
ROCI (R&D-adjusted, %): 25.607778709855516
FCF margin (%): 12.678818968455092
Rule of 40 score: 12.678818968455092
Financial ratios for ACLN.SW — annual report dated 2023-12-31
Total revenue: 1089117857.142857
Gross profit: 459442857.14285713
Operating income: 168221428.57142857
Net income: 130920238.0952381
Capital expenditures: 42992857.14285714
Operating cash flow: 172848809.52380952
Depreciation & amortization: 35866666.66666667
Net tangible assets: 243504761.9047619
Owner earnings: 123794047.61904764
Return on net tangible assets (%): 50.838450406758454
Capex to operating income (%): 25.557301176170867
Buffett classification: The Good
Stock price: 29.25
P/E ratio: 21.010482773862673
Shares outstanding: 94040937
Book value: 360597619.0476191
P/B ratio: 7.628162977101504
Market cap (USD): 2750697407.25
Debt to equity: 1.712177535968729
Current ratio: 2.3345668855457244
Quick ratio: 1.5683566331976424
Effective tax rate (%): 19.83189724299815
Interest coverage ratio: 34.23110465116279
COGS to revenue (%): 57.81513872629554
R&D to revenue (%): 6.2794375963946365
SG&A to revenue (%): 21.038214631981543
Free cash flow (dilution-adjusted): 129750000
Buyback yield (%): 0
Retained earnings: 266676190.47619048
Inventory turnover: 2.1112574692548107
Receivables turnover: 4.442011886033909
Capitalized R&D asset: 105595139.23395446
ROCI (R&D-adjusted, %): 16.938672479776105
Rosenberg metric: 1.3675382890251646
FCF margin (%): 11.913311231566832
Revenue growth (%): 28.37151151787979
Rule of 40 score: 40.28482274944662
Financial ratios for ACLN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 247026666.66666666
Buffett classification: The Gruesome
Stock price: 49.67777777777778
Shares outstanding: 94040937
Book value: 387986666.66666675
P/B ratio: 12.040993084727996
Market cap (USD): 4671744770.3
Debt to equity: 1.4930123601040124
Current ratio: 2.546069582273641
Quick ratio: 1.7416812114563072
Buyback yield (%): 0
Retained earnings: 352731111.1111111
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACLN.SW — annual report dated 2024-12-31
Total revenue: 1136140000
Gross profit: 523537777.7777778
Operating income: 264303333.3333333
Net income: 199281111.1111111
Capital expenditures: 42675555.55555555
Operating cash flow: 240142222.2222222
Depreciation & amortization: 40334444.44444444
Net tangible assets: 247026666.66666666
Owner earnings: 196940000
Return on net tangible assets (%): 79.72418632266422
Capex to operating income (%): 16.146431078768924
Buffett classification: The Great
Stock price: 49.67777777777778
P/E ratio: 23.442988370810635
Shares outstanding: 94040937
Book value: 387986666.66666675
P/B ratio: 12.040993084727996
Market cap (USD): 4671744770.3
Debt to equity: 1.4930123601040124
Current ratio: 2.546069582273641
Quick ratio: 1.7416812114563072
Effective tax rate (%): 20.568214530879782
Interest coverage ratio: 19.69473422752111
COGS to revenue (%): 53.9196069342002
R&D to revenue (%): 5.694916315086364
SG&A to revenue (%): 17.38576818584564
Free cash flow (dilution-adjusted): 197337777.77777776
Buyback yield (%): 0
Retained earnings: 352731111.1111111
Inventory turnover: 2.278687034006183
Receivables turnover: 5.3758871959875085
Capitalized R&D asset: 128848526.05244997
ROCI (R&D-adjusted, %): 22.83466031371031
Rosenberg metric: 0.9371907348094511
FCF margin (%): 17.369142691726175
Revenue growth (%): 4.31745219755176
Rule of 40 score: 21.686594889277934
Financial ratios for ACLN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 281045000
Buffett classification: The Gruesome
Stock price: 68.55
Shares outstanding: 94040937
Book value: 456515000
P/B ratio: 14.121126866258502
Market cap (USD): 6446506231.349999
Debt to equity: 1.6119815340131212
Current ratio: 2.196832124164251
Quick ratio: 1.5065658126450145
Buyback yield (%): 0
Retained earnings: 373480000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALADO.PA — annual report dated 2021-12-31
Total revenue: 7052272.7272727275
Operating income: -2190909.090909091
Net income: -2384090.909090909
Capital expenditures: 0
Operating cash flow: 2868181.8181818184
Depreciation & amortization: 4240909.090909091
Net tangible assets: -2847727.272727273
Owner earnings: 1856818.1818181816
Buffett classification: The Gruesome
Shares outstanding: 62390
Book value: 18059090.90909091
Debt to equity: 0.2937956204379562
Current ratio: 1.8742343813801552
Quick ratio: 1.2511229073091057
Interest coverage ratio: -13.1156462585034
COGS to revenue (%): 0
SG&A to revenue (%): 13.873670641314856
Free cash flow (dilution-adjusted): -756818.1818181818
Retained earnings: -2384090.909090909
Inventory turnover: 0
Receivables turnover: 10.291873963515755
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.341537865206648
FCF margin (%): -10.73155011279407
Rule of 40 score: -10.73155011279407
Financial ratios for ALADO.PA — annual report dated 2022-12-31
Total revenue: 6015957.446808511
Operating income: -3377659.574468085
Net income: -3477659.574468085
Capital expenditures: 4626595.744680852
Operating cash flow: 1419148.936170213
Depreciation & amortization: 4408510.638297873
Net tangible assets: -2344680.85106383
Owner earnings: -3695744.680851064
Buffett classification: The Gruesome
Shares outstanding: 62390
Book value: 17597872.340425532
Debt to equity: 0.21980413492927095
Current ratio: 1.6067766384306732
Quick ratio: 1.3611234953187696
Interest coverage ratio: -34.51086956521739
COGS to revenue (%): 0
SG&A to revenue (%): 18.762157382847036
Free cash flow (dilution-adjusted): -3207446.8085106383
Retained earnings: -3477659.574468085
Inventory turnover: 0
Receivables turnover: 8.067047075606277
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.672046991460586
FCF margin (%): -53.315649867374006
Revenue growth (%): -14.694770332073965
Rule of 40 score: -68.01042019944796
Financial ratios for ALADO.PA — annual report dated 2023-12-31
Total revenue: 1990000
Gross profit: 521111.1111111111
Operating income: -6728888.888888889
Net income: -6894444.444444444
Capital expenditures: 2514444.4444444445
Operating cash flow: 144444.44444444444
Depreciation & amortization: 5510000
Net tangible assets: -8505555.555555556
Owner earnings: -3898888.8888888885
Buffett classification: The Gruesome
Stock price: 1805555.5555555555
Shares outstanding: 62390
Book value: 10328888.88888889
P/B ratio: 10906.169320137691
Market cap (USD): 112648611111.11111
Debt to equity: 0.6967512908777967
Current ratio: 0.5050809183289424
Quick ratio: 0.45615355664283025
Interest coverage ratio: -114.26415094339623
COGS to revenue (%): 73.81351200446677
SG&A to revenue (%): 6.197654941373535
Free cash flow (dilution-adjusted): -2370000
Buyback yield (%): 0
Retained earnings: -6896666.666666666
Inventory turnover: 10.169230769230769
Receivables turnover: 6.2622377622377625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -38.39959419187115
FCF margin (%): -119.09547738693466
Revenue growth (%): -66.921308576481
Rule of 40 score: -186.01678596341566
Financial ratios for ALEUA.PA — annual report dated 2021-12-31
Total revenue: 36628409.09090909
Gross profit: 33418181.818181816
Operating income: 5648863.636363637
Net income: 26969318.181818184
Capital expenditures: 3738636.3636363638
Operating cash flow: -9681818.181818182
Depreciation & amortization: 0
Net tangible assets: 150692045.45454547
Owner earnings: 23230681.81818182
Return on net tangible assets (%): 15.415997405907591
Capex to operating income (%): 66.18386642526654
Buffett classification: The Good
Stock price: 5.227272727272727
P/E ratio: 1.468306316099945
Shares outstanding: 7575503
Book value: 196869318.18181816
P/B ratio: 0.20114470143438484
Market cap (USD): 39599220.22727272
Debt to equity: 0.32993737192992584
Current ratio: 0.6747685403428054
Quick ratio: 0.5400788188486414
Effective tax rate (%): 26.509922346850733
Interest coverage ratio: 3.138257575757576
COGS to revenue (%): 8.764309868768033
Free cash flow (dilution-adjusted): -20598863.636363637
Buyback yield (%): 1.5725745839267533
Retained earnings: 21845454.545454547
Inventory turnover: 0.39549209015819686
Receivables turnover: 1.5338091839162504
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.813168174904527
FCF margin (%): -56.23739645704712
Rule of 40 score: -56.23739645704712
Financial ratios for ALEUA.PA — annual report dated 2022-12-31
Total revenue: 33454255.31914894
Gross profit: 29376595.74468085
Operating income: 750000
Net income: 15957.44680851064
Capital expenditures: 6284042.55319149
Operating cash flow: -22455319.14893617
Depreciation & amortization: 0
Net tangible assets: 202473404.25531915
Owner earnings: -6268085.106382979
Return on net tangible assets (%): -3.0957572573230006
Capex to operating income (%): 837.872340425532
Buffett classification: The Gruesome
Stock price: 3.6595744680851063
P/E ratio: 1737.3153546666663
Shares outstanding: 7575503
Book value: 246085106.38297874
P/B ratio: 0.11265662424347225
Market cap (USD): 27723117.361702126
Debt to equity: 0.31743039944665397
Current ratio: 0.6331864152599719
Quick ratio: 0.5669452623493481
Effective tax rate (%): 99.76215251969674
Interest coverage ratio: 0.10494194700803809
COGS to revenue (%): 12.188762044074156
Free cash flow (dilution-adjusted): -24087234.042553194
Buyback yield (%): 0
Retained earnings: 5319.148936170213
Inventory turnover: 1.0582551076753175
Receivables turnover: 1.8500411813154491
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.1846589048810194
FCF margin (%): -72.00050879257162
Revenue growth (%): -8.665824835258697
Rule of 40 score: -80.66633362783031
Financial ratios for ALEXP.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.272727272727273
Shares outstanding: 12068260
Market cap (USD): 27427863.63636364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALEXP.PA — annual report dated 2022-12-31
Total revenue: 3280851.0638297875
Gross profit: 1832978.7234042555
Operating income: -146808.51063829788
Net income: -681914.8936170213
Capital expenditures: 497872.34042553196
Operating cash flow: 11702.12765957447
Depreciation & amortization: 334042.55319148937
Net tangible assets: -228723.40425531915
Owner earnings: -845744.6808510639
Buffett classification: The Gruesome
Stock price: 1.2659574468085106
Shares outstanding: 12068260
Book value: 7863829.787234043
P/B ratio: 1.9428070075757575
Market cap (USD): 15277903.617021276
Debt to equity: 0.5125811688311689
Current ratio: 0.26782093277179847
Quick ratio: 0.2676649508656996
Interest coverage ratio: -2
COGS to revenue (%): 44.130998702983135
SG&A to revenue (%): 46.98443579766537
Free cash flow (dilution-adjusted): -486170.21276595746
Buyback yield (%): 0
Retained earnings: -682978.7234042553
Inventory turnover: 1361
Receivables turnover: 4.841444270015699
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.8666305965102123
FCF margin (%): -14.818417639429313
Rule of 40 score: -14.818417639429313
Financial ratios for ALEXP.PA — annual report dated 2023-12-31
Total revenue: 5572222.222222222
Gross profit: 1871111.111111111
Operating income: -622222.2222222222
Net income: -784444.4444444444
Capital expenditures: 984444.4444444444
Operating cash flow: 467777.77777777775
Depreciation & amortization: 413333.3333333333
Net tangible assets: -546666.6666666666
Owner earnings: -1355555.5555555555
Buffett classification: The Gruesome
Stock price: 0.4888888888888889
Shares outstanding: 12068260
Book value: 9012222.22222222
P/B ratio: 0.6546707434348417
Market cap (USD): 5900038.222222222
Debt to equity: 0.5077055850080139
Current ratio: 0.3455280113574315
Quick ratio: 0.3452003931418587
Interest coverage ratio: -7.567567567567568
COGS to revenue (%): 66.42073778664009
Free cash flow (dilution-adjusted): -516666.6666666666
Buyback yield (%): 0
Retained earnings: -781111.1111111111
Inventory turnover: 1110.3333333333335
Receivables turnover: 4.217830109335576
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.903353057199212
FCF margin (%): -9.272183449651045
Revenue growth (%): 69.84075515203918
Rule of 40 score: 60.568571702388134
Financial ratios for ALEXP.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -1334375
Buffett classification: The Gruesome
Stock price: 0.33333333333333337
Shares outstanding: 12068260
Book value: 7032291.666666666
P/B ratio: 0.5720401718263962
Market cap (USD): 4022753.333333334
Debt to equity: 0.3337283365427344
Current ratio: 0.4605590516610566
Quick ratio: 0.4605590516610566
Buyback yield (%): 0
Retained earnings: -1381250
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALEXP.PA — annual report dated 2024-12-31
Total revenue: 4413541.666666667
Gross profit: 1243750
Operating income: -683333.3333333334
Net income: -1381250
Capital expenditures: 100000
Operating cash flow: 287500
Depreciation & amortization: 304166.6666666667
Net tangible assets: -1334375
Owner earnings: -1177083.3333333333
Buffett classification: The Gruesome
Stock price: 0.33333333333333337
Shares outstanding: 12068260
Book value: 7032291.666666666
P/B ratio: 0.5720401718263962
Market cap (USD): 4022753.333333334
Debt to equity: 0.3337283365427344
Current ratio: 0.4605590516610566
Quick ratio: 0.4605590516610566
Interest coverage ratio: -4.287581699346405
COGS to revenue (%): 71.81968373849422
SG&A to revenue (%): 1.746518763275903
Free cash flow (dilution-adjusted): 187500
Buyback yield (%): 0
Retained earnings: -1381250
Receivables turnover: 5.976022566995768
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.721398933017191
FCF margin (%): 4.248288883644088
Revenue growth (%): -20.793868394815547
Rule of 40 score: -16.54557951117146
Financial ratios for ALEXP.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.0941176470588236
Shares outstanding: 12068260
Market cap (USD): 25272356.23529412
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALIMP.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.3522727272727273
Shares outstanding: 143818971
Market cap (USD): 50663501.14772727
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALIMP.PA — annual report dated 2022-12-31
Total revenue: 8540425.531914894
Gross profit: 5277659.574468086
Operating income: -4453191.489361702
Net income: -3765957.446808511
Capital expenditures: 229787.2340425532
Operating cash flow: -2557446.8085106383
Depreciation & amortization: 652127.6595744682
Net tangible assets: -1703191.4893617022
Owner earnings: -3343617.021276596
Buffett classification: The Gruesome
Stock price: 0.18085106382978725
Shares outstanding: 143818971
Book value: 3767021.2765957434
P/B ratio: 6.904610299350469
Market cap (USD): 26009813.90425532
Debt to equity: 1.9203614798079645
Current ratio: 1.0264238070805543
Quick ratio: 0.6032580810672141
Interest coverage ratio: -9.06060606060606
COGS to revenue (%): 38.191330343796714
R&D to revenue (%): 11.497259591429996
SG&A to revenue (%): 39.93522670652716
Free cash flow (dilution-adjusted): -3315957.446808511
Buyback yield (%): 0
Retained earnings: -3765957.446808511
Inventory turnover: 0.9293725371324644
Receivables turnover: 4.247619047619048
Capitalized R&D asset: 981914.8936170214
ROCI (R&D-adjusted, %): -46.97009558888012
FCF margin (%): -38.82660687593423
Rule of 40 score: -38.82660687593423
Financial ratios for ALIMP.PA — annual report dated 2023-12-31
Total revenue: 8274444.444444444
Gross profit: 4703333.333333333
Operating income: -4856666.666666667
Net income: -7417777.777777778
Capital expenditures: 331111.1111111111
Operating cash flow: -1607777.7777777778
Depreciation & amortization: 633333.3333333334
Net tangible assets: -3632222.222222222
Owner earnings: -7115555.555555556
Buffett classification: The Gruesome
Stock price: 0.06666666666666667
Shares outstanding: 143818971
Book value: -193333.33333333395
Market cap (USD): 9587931.4
Debt to equity: -35.356321839080344
Current ratio: 0.7148115101494535
Quick ratio: 0.29321882667856347
Interest coverage ratio: -16.309701492537314
COGS to revenue (%): 43.17174701221968
R&D to revenue (%): 12.071975292063918
SG&A to revenue (%): 38.17644689136566
Free cash flow (dilution-adjusted): -2402222.222222222
Buyback yield (%): 0
Retained earnings: -7417777.777777778
Inventory turnover: 0.8505291005291005
Receivables turnover: 4.4619532654283995
Capitalized R&D asset: 1656771.8676122932
ROCI (R&D-adjusted, %): -128.59327582365
Rosenberg metric: -0.5849042975803546
FCF margin (%): -29.031824895931248
Revenue growth (%): -3.114377456679404
Rule of 40 score: -32.14620235261065
Financial ratios for ALIMP.PA — annual report dated 2024-12-31
Total revenue: 9797916.666666668
Gross profit: 5197916.666666667
Operating income: -5013541.666666667
Net income: -4547916.666666667
Capital expenditures: 506250
Operating cash flow: -2282291.666666667
Depreciation & amortization: 554166.6666666667
Net tangible assets: -2138541.666666667
Owner earnings: -4500000
Buffett classification: The Gruesome
Stock price: 0.11458333333333334
Shares outstanding: 143818971
Book value: 757291.6666666679
P/B ratio: 21.76077965612101
Market cap (USD): 16479257.093750002
Debt to equity: 8.488308115543315
Current ratio: 0.8450450450450452
Quick ratio: 0.38288288288288297
Interest coverage ratio: -21.017467248908297
COGS to revenue (%): 46.93812460131831
R&D to revenue (%): 6.644694875611313
SG&A to revenue (%): 34.54178184137784
Free cash flow (dilution-adjusted): -3089583.3333333335
Buyback yield (%): 0
Retained earnings: -4547916.666666667
Inventory turnover: 0.7823852560694667
Receivables turnover: 4.244584837545126
Capitalized R&D asset: 1644329.1371158396
ROCI (R&D-adjusted, %): -118.11962968772367
Rosenberg metric: 0.49513348164627424
FCF margin (%): -31.53306400170104
Revenue growth (%): 18.411776554317196
Rule of 40 score: -13.121287447383843
Financial ratios for ALIMP.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -2138541.666666667
Buffett classification: The Gruesome
Stock price: 0.11458333333333334
Shares outstanding: 143818971
Book value: 757291.6666666679
P/B ratio: 21.76077965612101
Market cap (USD): 16479257.093750002
Debt to equity: 8.488308115543315
Current ratio: 0.8450450450450452
Quick ratio: 0.38288288288288297
Buyback yield (%): 0
Retained earnings: -4547916.666666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALIMP.PA — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -4702352.94117647
Buffett classification: The Gruesome
Stock price: 0.11764705882352942
Shares outstanding: 143818971
Book value: -1604705.8823529407
Market cap (USD): 16919878.941176474
Debt to equity: -4.483870967741937
Current ratio: 0.7170613236187006
Quick ratio: 0.24851244687310262
Buyback yield (%): 0
Retained earnings: -2467058.823529412
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMBR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 46.1
Shares outstanding: 87028604
Market cap (USD): 4012018644.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMBR — annual report dated 2022-12-31
Total revenue: 34754477.611940295
Gross profit: 17885074.62686567
Operating income: -8169402.985074626
Net income: -149906716.41791043
Capital expenditures: 67164.1791044776
Operating cash flow: 53062686.567164175
Depreciation & amortization: 1776119.4029850746
Net tangible assets: 55178358.20895522
Owner earnings: -148197761.19402984
Return on net tangible assets (%): -268.57950472686946
Buffett classification: The Gruesome
Stock price: 3.85
Shares outstanding: 87028604
Book value: 59170895.522388056
P/B ratio: 5.662583309614196
Market cap (USD): 335060125.40000004
Debt to equity: 0.6030344688418319
Current ratio: 1.4861018327572686
Quick ratio: 1.4861018327572686
Interest coverage ratio: -179.45901639344262
COGS to revenue (%): 48.53879023426596
R&D to revenue (%): 3.8865388331794466
SG&A to revenue (%): 74.65590174142707
Free cash flow (dilution-adjusted): 50137313.43283582
Buyback yield (%): 1.6869326958027064
Retained earnings: -315008955.2238806
Receivables turnover: 0.6655376920328688
Capitalized R&D asset: 1350746.2686567164
ROCI (R&D-adjusted, %): -11.34232303942118
FCF margin (%): 144.26145025874473
Rule of 40 score: 144.26145025874473
Financial ratios for AMBR — annual report dated 2023-12-31
Total revenue: 2071212.121212121
Gross profit: 885606.0606060605
Operating income: -2740151.515151515
Net income: -10254545.454545453
Capital expenditures: 0
Operating cash flow: 8684848.484848484
Depreciation & amortization: 560606.0606060605
Net tangible assets: -16459090.909090908
Owner earnings: -9693939.393939393
Buffett classification: The Gruesome
Stock price: 3.83
Shares outstanding: 87028604
Book value: -3445454.545454543
Market cap (USD): 333319553.32
Debt to equity: 0
Current ratio: 0.4751805599169062
Quick ratio: 0.4751805599169062
Interest coverage ratio: -24.944827586206898
COGS to revenue (%): 57.242136064374534
R&D to revenue (%): 16.38624725676664
SG&A to revenue (%): 159.65618141916607
Free cash flow (dilution-adjusted): 8684848.484848484
Buyback yield (%): 0
Retained earnings: -10315909.09090909
Receivables turnover: 0.14847398718366459
Capitalized R&D asset: 1244393.9393939395
Rosenberg metric: -12.58524192198225
FCF margin (%): 419.31236283833215
Revenue growth (%): -94.0404452504257
Rule of 40 score: 325.27191758790644
Financial ratios for AMBR — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3
Shares outstanding: 87028604
Market cap (USD): 287194393.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AMBR — annual report dated 2024-12-31
Total revenue: 5496323.529411764
Gross profit: 1834558.8235294116
Operating income: -3879411.764705882
Net income: -17112500
Capital expenditures: 0
Operating cash flow: -408088.2352941176
Depreciation & amortization: 278676.4705882353
Net tangible assets: 9477941.176470587
Owner earnings: -16833823.529411763
Return on net tangible assets (%): -177.61055081458494
Buffett classification: The Gruesome
Stock price: 9.36
Shares outstanding: 87028604
Book value: 21900735.294117644
P/B ratio: 37.19453810570422
Market cap (USD): 814587733.4399999
Debt to equity: 0.02400537183145879
Current ratio: 1.127264874854365
Quick ratio: 1.127264874854365
Interest coverage ratio: -114.69565217391303
COGS to revenue (%): 66.62207357859532
R&D to revenue (%): 6.046822742474917
SG&A to revenue (%): 98.31438127090301
Free cash flow (dilution-adjusted): -463970.5882352941
Buyback yield (%): 0
Retained earnings: -27124999.999999996
Receivables turnover: 0.09172904650877407
Capitalized R&D asset: 1005493.1492271264
ROCI (R&D-adjusted, %): -18.14577283536456
Rosenberg metric: 2.796021533613445
FCF margin (%): -8.441471571906355
Revenue growth (%): 165.3674856921554
Rule of 40 score: 156.92601412024905
Financial ratios for AMBR — quarterly report dated 2024-12-31
Total revenue: 22152205.88235294
Gross profit: 11499264.705882352
Operating income: -9550735.294117646
Net income: -13112499.999999998
Capital expenditures: 0
Net tangible assets: 9477941.176470587
Owner earnings: -13112499.999999998
Return on net tangible assets (%): -138.34755624515128
Buffett classification: The Gruesome
Stock price: 9.36
Shares outstanding: 87028604
Book value: 21900735.294117644
P/B ratio: 37.19453810570422
Market cap (USD): 814587733.4399999
Debt to equity: 0.02400537183145879
Current ratio: 1.127264874854365
Quick ratio: 1.127264874854365
COGS to revenue (%): 48.089753377369135
R&D to revenue (%): 1.842201347628373
SG&A to revenue (%): 93.40458724731967
Buyback yield (%): 0
Retained earnings: -27124999.999999996
Receivables turnover: 0.3697018039023193
Capitalized R&D asset: 408088.2352941176
ROCI (R&D-adjusted, %): -40.93755068937553
Rule of 40 score: 0
Financial ratios for AMBR — quarterly report dated 2025-03-31
Total revenue: 10826119.402985074
Gross profit: 8170149.253731343
Operating income: 632835.8208955224
Net income: 694776.1194029851
Capital expenditures: 0
Owner earnings: 694776.1194029851
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 11.98
P/E ratio: 375.1577834943072
Shares outstanding: 87028604
Market cap (USD): 1042602675.9200001
Effective tax rate (%): 0.5307855626326964
Interest coverage ratio: 28.266666666666666
COGS to revenue (%): 24.53298407665265
R&D to revenue (%): 23.31977665954367
SG&A to revenue (%): 46.30178534500586
Buyback yield (%): 0
Capitalized R&D asset: 2798045.9833187005
ROCI (R&D-adjusted, %): 77.90761836085781
Rosenberg metric: -8.157832459324997
Revenue growth (%): -51.12848146825206
Rule of 40 score: -51.12848146825206